These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Changes in whole blood viscosity at low shear rates correlate with intravascular volume changes during hemodialysis. Kim W; Park SK; Kang KP; Lee DH; Kim SY; Jung JM; Cho YI Int J Artif Organs; 2012 Jun; 35(6):425-34. PubMed ID: 22669590 [TBL] [Abstract][Full Text] [Related]
24. Cefazolin dialytic clearance by high-efficiency and high-flux hemodialyzers. Sowinski KM; Mueller BA; Grabe DW; Manley HJ; Frye RF; Bailie GR; Marx MA Am J Kidney Dis; 2001 Apr; 37(4):766-76. PubMed ID: 11273877 [TBL] [Abstract][Full Text] [Related]
26. Low thrombogenicity of polyethylene glycol-grafted cellulose membranes does not influence heparin requirements in hemodialysis. Wright MJ; Woodrow G; Umpleby S; Hull S; Brownjohn AM; Turney JH Am J Kidney Dis; 1999 Jul; 34(1):36-42. PubMed ID: 10401013 [TBL] [Abstract][Full Text] [Related]
27. Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells. Kobayashi S; Moriya H; Aso K; Ohtake T Kidney Int; 2003 May; 63(5):1881-7. PubMed ID: 12675867 [TBL] [Abstract][Full Text] [Related]
28. Does treatment modality have an impact on anemia in patients with chronic renal failure? Effect of low- and high-flux biocompatible dialysis. Opatrný K; Reischig T; Vienken J; Eiselt J; Vít L; Opatrná S; Sefrna F; Racek J; Brown GS Artif Organs; 2002 Feb; 26(2):181-8. PubMed ID: 11879248 [TBL] [Abstract][Full Text] [Related]
29. [Hemorheological changes induced by uremia. Effects of hemodialysis]. Delsignore R; David S; Francia MT; Bottazzi G; Crotti G Ric Clin Lab; 1985; 15 Suppl 1():335-45. PubMed ID: 4035225 [TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation. Klingel R; Schaefer M; Schwarting A; Himmelsbach F; Altes U; Uhlenbusch-Körwer I; Hafner G Nephrol Dial Transplant; 2004 Jan; 19(1):164-70. PubMed ID: 14671052 [TBL] [Abstract][Full Text] [Related]
31. [Correlation of complement activation, cytokine liberation and beta 2 microglobulin in the use of various dialysis and hemofiltration membranes]. Falkenhagen D; Thomaneck U; Brown GS; Werner H; Klinkmann H Z Urol Nephrol; 1989 Oct; 82(10):541-50. PubMed ID: 2692346 [TBL] [Abstract][Full Text] [Related]
32. Effect of different dialyzer membranes on cutaneous microcirculation during hemodialysis. Sato M; Morita H; Ema H; Yamaguchi S; Amano I Clin Nephrol; 2006 Dec; 66(6):426-32. PubMed ID: 17176914 [TBL] [Abstract][Full Text] [Related]
33. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients]. García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513 [TBL] [Abstract][Full Text] [Related]
34. Influence of hemoultrafiltration and hemodialysis on endothelin. Lin SY; Chen LQ; Wang YH; Zhou JH Chin Med J (Engl); 1991 Apr; 104(4):288-91. PubMed ID: 2065545 [TBL] [Abstract][Full Text] [Related]
35. A comparison of solute clearance during continuous hemofiltration, hemodiafiltration, and hemodialysis using a polysulfone hemofilter. Reeves JH; Butt WW ASAIO J; 1995; 41(1):100-4. PubMed ID: 7727810 [TBL] [Abstract][Full Text] [Related]
36. Failure of platelet markers to evaluate membrane biocompatibility during a combined hemodialysis-hemoperfusion treatment. Buccianti G; Giaretto S; Pogliani EM; Lorenz M; Valenti G; Bianchi ML; Cresseri D Artif Organs; 1987 Oct; 11(5):416-20. PubMed ID: 2961320 [TBL] [Abstract][Full Text] [Related]
37. Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Ronco C; Brendolan A; Lupi A; Metry G; Levin NW Kidney Int; 2000 Aug; 58(2):809-17. PubMed ID: 10916106 [TBL] [Abstract][Full Text] [Related]
38. [Correction of blood rheological disorders in patients with chronic kidney failure using heparin and antiaggregants]. Vorob'ev PA; Dvoretskiĭ LI; Aĭnabekova BA; Iaroslavtseva GN; Miagkov AV Ter Arkh; 1988; 60(5):73-6. PubMed ID: 3175933 [TBL] [Abstract][Full Text] [Related]
39. [Ways of intensification of hemodialysis therapy]. Filiptsev PIa; Kirkhman VV; Timokhov VS Ter Arkh; 1988; 60(6):44-7. PubMed ID: 3206368 [TBL] [Abstract][Full Text] [Related]
40. Short hemodialysis. von Albertini B; Bosch JP Am J Nephrol; 1991; 11(3):169-73. PubMed ID: 1962662 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]